advertisement

Topcon

Labbé A 11

Showing records 1 to 11 | Display all abstracts from Labbé A

95048 A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
Nieland K
PLoS ONE 2021; 16: e0252130
94449 PreserFlo MicroShunt® exposure: a case series
Bunod R; Robin M
BMC Ophthalmology 2021; 21: 273
95048 A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
Labbé A
PLoS ONE 2021; 16: e0252130
94449 PreserFlo MicroShunt® exposure: a case series
Buffault J
BMC Ophthalmology 2021; 21: 273
95048 A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
Schweitzer C
PLoS ONE 2021; 16: e0252130
94449 PreserFlo MicroShunt® exposure: a case series
Keilani C
BMC Ophthalmology 2021; 21: 273
95048 A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
Gicquel G
PLoS ONE 2021; 16: e0252130
94449 PreserFlo MicroShunt® exposure: a case series
Labbé A
BMC Ophthalmology 2021; 21: 273
95048 A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
Kleintjens J
PLoS ONE 2021; 16: e0252130
94449 PreserFlo MicroShunt® exposure: a case series
Baudouin C
BMC Ophthalmology 2021; 21: 273
95048 A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
Ostawal A; Treur M; Falvey H
PLoS ONE 2021; 16: e0252130

Issue 22-2

Change Issue


advertisement

Oculus